Home

Radioaktiv Historiker juni reuters teva konsol Ged Spytte

Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Names Interim CEO, New Chairman As Vigodman Steps Down

Teva lied about opioid role, New York says | Reuters
Teva lied about opioid role, New York says | Reuters

Teva, Texas strike opioid settlement worth $225M | Business Insurance
Teva, Texas strike opioid settlement worth $225M | Business Insurance

Averting opioid trial, Teva, drug distributors reach last-gasp settlement -  The Jerusalem Post
Averting opioid trial, Teva, drug distributors reach last-gasp settlement - The Jerusalem Post

Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters

A Teva Pharmaceutical Industries building is seen in Jerusalem December 14,  2017. REUTERS/Ammar Awad Stock Photo - Alamy
A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad Stock Photo - Alamy

Opioid Maker Teva Proposes $4.35 Billion in Nationwide Settlement -  Business - Haaretz.com
Opioid Maker Teva Proposes $4.35 Billion in Nationwide Settlement - Business - Haaretz.com

Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year:  Report
Teva To Start Nationwide Settlement Of Opioid Lawsuits From Next Year: Report

Teva Pharmaceuticals at heart of major price fixing suit in US -  www.israelhayom.com
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com

Teva may pay as much as $3.6 billion in opioid settlement | Business  Insurance
Teva may pay as much as $3.6 billion in opioid settlement | Business Insurance

Teva could pay $3.6b to settle opioid dispute - report - Globes
Teva could pay $3.6b to settle opioid dispute - report - Globes

Teva faces class-action lawsuit over US antitrust probe into price-fixing |  The Times of Israel
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel

Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters

Teva CEO Exits Amid Crisis of Confidence at Drugmaker
Teva CEO Exits Amid Crisis of Confidence at Drugmaker

Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend

San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters

Teva expects to start paying U.S. opioid settlement in 2023: CEO | Business  Insurance
Teva expects to start paying U.S. opioid settlement in 2023: CEO | Business Insurance

Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva Pharm Expects About 25 Percent of EpiPen Market by Year End

TEVA.N) | Stock Price & Latest News | Reuters
TEVA.N) | Stock Price & Latest News | Reuters

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN  Business
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business

TEVA.TA - | Stock Price & Latest News | Reuters
TEVA.TA - | Stock Price & Latest News | Reuters